Fundraising Fox
Vincere Biosciences
Founded 2018 · 10 employees on LinkedIn · 7 known investors
Find your way into Vincere Biosciences
Sign up to find every way you can get introduced to Vincere Biosciences
- Your email: who you already know at Vincere Biosciences, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Vincere Biosciences team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Vincere Biosciences develops small-molecule therapeutics targeting mitochondrial quality control and mitophagy, primarily for neurodegenerative diseases including Parkinson's disease. The company translates computational biology and drug discovery into disease-modifying treatments for CNS disorders.
Investors · 7
How we know: av.vc · Not right? Tell us
How we know: Freemind Investments's portfolio page · Not right? Tell us
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $470.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $299.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2020 | $252K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Vincere Biosciences do?
- Vincere Biosciences develops small-molecule therapeutics targeting mitochondrial quality control and mitophagy, primarily for neurodegenerative diseases including Parkinson's disease. The company translates computational biology and drug discovery into disease-modifying treatments for CNS disorders.
- Who are Vincere Biosciences's investors?
- Vincere Biosciences's investors include Alumni Ventures, Beiersdorf Innovation Fund, Beresford Ventures, Draper Associates, Freemind Investments, Portal Innovations, quadraScope Venture Fund.